List of Excipients in API brivaracetam
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing brivaracetam
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | ANHYDROUS LACTOSE | |
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | BETADEX | |
| UCB Inc | BRIVIACT | brivaracetam | 50474-370 | CROSCARMELLOSE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing brivaracetam
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 | CARBOXYMETHYLCELLULOSE SODIUM |
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 | CITRIC ACID |
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 | GLYCERIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for brivaracetam
Excipient focus: ACETIC ACID
brivaracetam drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-272 |
| PAI Holdings LLC dba PAI Pharma | brivaracetam injection | 0121-1075 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
brivaracetam drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| Zhejiang Poly Pharm Co Ltd | brivaracetam | 72673-031 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
brivaracetam drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| Zydus Lifesciences Limited | brivaracetam | 70771-1754 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: BETADEX
brivaracetam drug variants containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
brivaracetam drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
brivaracetam drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID
brivaracetam drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
brivaracetam drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
brivaracetam drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | brivaracetam | 84386-070 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
brivaracetam drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | brivaracetam | 84386-070 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
brivaracetam drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO AND DICAPRYLOCAPRATE
brivaracetam drug variants containing GLYCERYL MONO AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing GLYCERYL MONO AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
brivaracetam drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | brivaracetam | 70771-1754 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
brivaracetam drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
brivaracetam drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
brivaracetam drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN SODIUM
brivaracetam drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Florida Pharmaceutical Products LLC | brivaracetam oral | 71921-410 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
brivaracetam drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
brivaracetam drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-267 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
brivaracetam drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Solaris Pharma Corporation | brivaracetam | 73473-904 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
brivaracetam drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
brivaracetam drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-272 |
| PAI Holdings LLC dba PAI Pharma | brivaracetam injection | 0121-1075 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
brivaracetam drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-272 |
| PAI Holdings LLC dba PAI Pharma | brivaracetam injection | 0121-1075 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
brivaracetam drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Zhejiang Poly Pharm Co Ltd | brivaracetam | 72673-031 |
| Florida Pharmaceutical Products LLC | brivaracetam oral | 71921-410 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
brivaracetam drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| Zydus Lifesciences Limited | brivaracetam | 70771-1754 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
brivaracetam drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| Zhejiang Poly Pharm Co Ltd | brivaracetam | 72673-031 |
| Florida Pharmaceutical Products LLC | brivaracetam oral | 71921-410 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
brivaracetam drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
brivaracetam drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
brivaracetam drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
brivaracetam drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
brivaracetam drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| Novadoz Pharmaceuticals LLC | brivaracetam | 72205-033 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| UCB Inc | brivaracetam | 50474-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
brivaracetam drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | brivaracetam | 0121-1074 |
| Hainan Poly Pharm Co Ltd | brivaracetam | 14335-420 |
| Ascend Laboratories LLC | brivaracetam | 67877-904 |
| >Company | >Ingredient | >NDC |
brivaracetam drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| UCB Inc | brivaracetam | 50474-370 |
| Apotex Corp | brivaracetam | 60505-4723 |
| Zydus Pharmaceuticals USA Inc | brivaracetam | 70710-1584 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
